The department of ophthalmology at the University Hospital of Cologne is very proud to announce that Dr. Karina Hadrian won the Sicca advancement award for research of the dry eye and surface disease of the eye of the BVA. This prize is awarded by Bausch + Lomb on the annual […]

Consensus Definition for Atrophy Associated with Age-Related Macular Degeneration on OCT: Classification of Atrophy Report 3 is one of the most quoted papers according to the Elsevier Most Cited Ophthalmology Articles overview https://bit.ly/3224En0 As part of the Classification of Atrophy Meetings (CAM) program, Prof. Dr. Sandra Liakopoulos of the Department […]

We are proud to announce that Ms Dr. Simona Schlereth and Ms Dr. Andrea Hedergott were selected to attend the MhÄK Mentoring program of the Medical Faculty at the University of Cologne.  The program is implemented for female physicians who are qualifying as a professor and runs this year for […]

Professor Dr. Claus Cursiefen, Chairman of the Department of Ophthalmology of the University Hospital Cologne and Speaker of DFG FOR2240, has been re-elected to the DFG Review Board representing Ophthalmology . With him Professor Dr. Marius Ader from Regenerative Therapies Dresden, Technische Universität Dresden, Germany – CRTD Dresden received the […]

We were honored to welcome Prof. De Paiva last Tuesday (12th of November 2019) at the Hospital University of Cologne. The Ocular Surface Group, led by Prof. Philipp Steven and Dr. Uta Gehlsen invited Prof. De Paiva to collaborate on aging aspects in dry-eye disease and ocular Graft-versus-Host Disease. The […]

Priv. – Doz. Dr. Sebastian Siebelmann, consulting physician at the department of ophthalmology of the University Hospital Cologne attended the Young Physician Leaders Program (YPL) of the Interacademy Partnership Alliance (IAP) and the M8 Alliance of Academic Health Centers and Medical Universities. The YPL-Program brings young ambitious leaders from all […]

ANIRIDIA-NET(https://aniridia-net.eu/) is a pan-European bottom-up network of researchers, ophthalmologist, trainees, aniridia patient organizations, industry and special interest groups funded by the European Cooperation in Science and Technology (COST) program (link) to improve aniridia clinical management and promote innovative research and development of new alternatives for its diagnosis and treatment. The […]